Acute pain therapeutics pipeline assessment and market forecasts to 2019Document Transcript
Acute Pain Therapeutics - Pipeline Assessment and Market Forecasts to2019GlobalData, the industry analysis specialist, has released its new report, “Acute PainTherapeutics - Pipeline Assessment and Market Forecasts to 2019”. The report is anessential source of information and analysis on the global Acute Pain Therapeutics market.The report identifies the key trends shaping and driving the global Acute Pain Therapeuticsmarket. The report also provides insights on the prevalent competitive landscape and theemerging players expected to significantly alter the market positioning of the currentmarket leaders. Most importantly, the report provides valuable insights on the pipelineproducts within the global Acute Pain Therapeutics sector. This report is built using dataand information sourced from proprietary databases, primary and secondary research andin-house analysis by GlobalData’s team of industry experts.ScopeThe report provides information on the key drivers and challenges of the Acute Pain Therapeuticsmarket. Its scope includes -- Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Acute PainTherapeutics market revenues data from 2006 to 2011, forecast for eight years to 2019.- Pipeline analysis data providing a split across the different phases, mechanisms of action beingdeveloped and emerging trends by seven key markets. Pipeline candidates fall under major therapeuticclasses.- Analysis of the current and future competition in the seven key countries Acute Pain Therapeuticsmarket.- Insightful review of the key industry drivers, restraints and challenges. Each trend is independentlyresearched to provide a qualitative analysis of its implications.- Key topics covered include strategic competitor assessment, market characterization, unmet needs andthe implications for the Acute Pain Therapeutics market.- Analysis of key recent licensing and partnership agreements in Acute Pain Therapeutics marketGet more information of this report @ http://www.reportsnreports.com/reports/167921-acute-pain-therapeutics-pipeline-assessment-and-market-forecasts-to-2019.htmlReasons to buyThe report will enhance your decision making capability. It will allow you to -- Develop and design your in-licensing and out-licensing strategies through a review of pipeline productsand technologies and by identifying the companies with the most robust pipeline.- Develop business strategies by understanding the trends shaping and driving the global Acute PainTherapeutics market.- Drive revenues by understanding the key trends, innovative products and technologies, marketsegments and companies likely to impact the global Acute Pain Therapeutics market in future.- Formulate effective sales and marketing strategies by understanding the competitive landscape and byanalyzing the performance of various competitors.- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.- Organize your sales and marketing efforts by identifying the market categories and segments that
present maximum opportunities for consolidations, investments and strategic partnerships.- What’s the next big thing in the global Acute Pain Therapeutics market landscape? – Identify,understand and capitalize.Report Details:Published: June 2012No. of Pages: 98Price: Single User License: US $ 3995 Corporate User License: US $ 11985Major points covered in Table of Contents of this report include:List of Tables 51.2 List of Figures 62 Acute Pain Therapeutics - Introduction 72.1 Disease Overview 72.2 Epidemiology 82.3 Etiology 112.4 Pathophysiology 112.5 Symptoms 132.6 Diagnosis 142.6.1 Unidimensional Pain Intensity Scales 142.6.2 Multidimensional Pain Scales 162.6.3 Commonly Used Diagnosis Tests 162.7 Treatment and Management Options 162.7.1 Pharmacologic Therapy 162.7.2 Intervention/Surgical Procedures 172.7.3 Non-Pharmacologic Approaches 172.8 Referral Pathway 192.9 GlobalData Pipeline Report Guidance 203 Acute Pain Therapeutics - Market Characterization 213.1 Acute Pain Therapeutics Market Size (2006-2011) - Global 213.2 Acute Pain Therapeutics Market Forecast (2011-2019) - Global 233.3 Acute Pain Therapeutics Market Size (2006-2011) - The US 243.4 Acute Pain Therapeutics Market Forecast (2011- 2019) - The US 253.5 Acute Pain Therapeutics Market Size (2006-2011) - France 263.6 Acute Pain Therapeutics Market Forecast (2011-2019) - France 273.7 Acute Pain Therapeutics Market Size (2006-2011) - Germany 283.8 Acute Pain Therapeutics Market Forecast (2011-2019) - Germany 29
3.9 Acute Pain Therapeutics Market Size (2006-2011) - Italy 303.10 Acute Pain Therapeutics Market Forecast (2011-2019) - Italy 313.11 Acute Pain Therapeutics Market Size (2006-2011) - Spain 323.12 Acute Pain Therapeutics Market Forecast (2011-2019) - Spain 333.13 Acute Pain Therapeutics Market Size (2006-2011) - The UK 343.14 Acute Pain Therapeutics Market Forecast (2011-2019) - The UK 353.15 Acute Pain Therapeutics Market Size (2006-2011) - Japan 363.16 Acute Pain Therapeutics Market Forecast (2011-2019) - Japan 373.17 Drivers and Barriers for the Acute Pain Therapeutics Market 383.17.1 Drivers for the Acute Pain Therapeutics Market 383.17.2 Barriers for the Acute Pain Therapeutics Market 383.18 Opportunity and Unmet Need 383.19 Key Takeaway 404 Acute Pain Therapeutics - Competitive Assessment 414.1 Overview 414.2 Strategic Competitor Assessment 414.3 Product Profiles for the Major Marketed Products in the Acute Pain Therapeutics Market 424.3.1 Celebrex (celecoxib) 424.3.2 DepoDur (morphine sulfate extended-release liposome injection) 434.3.3 Ofirmev (acetaminophen injection) 454.3.4 Oxecta (oxycodone hydrochloride Tablet) 464.3.5 Nucynta (tapentadol) 474.3.6 Dilaudid (hydromorphone hydrochloride) 494.3.7 Sprix (ketorolac tromethamine) Nasal Spray 504.3.8 Zipsor (diclofenac potassium) 514.3.9 Flector Patch (diclofenac epolamine) 524.3.10 Vicoprofen (hydrocodone bitartrate 7.5mg and ibuprofen 200mg) 544.4 Key Takeaway 565 Acute Pain Therapeutics - Pipeline Assessment 575.1 Overview 575.2 Strategic Pipeline Assessment 575.3 Acute Pain Therapeutics Pipeline - Pipeline by Phases of Development 585.3.1 Acute Pain Therapeutics - Filed Pipeline 585.3.2 Acute Pain Therapeutics - Phase III Pipeline 595.3.3 Acute Pain Therapeutics - Phase II Pipeline 595.3.4 Acute Pain Therapeutics - Phase I Pipeline 605.3.5 Acute Pain Therapeutics - IND Filed Pipeline 605.3.6 Acute Pain Therapeutics - Pre-clinical Pipeline 605.3.7 Technology Trends Analytic Framework 615.4 Acute Pain Therapeutics Market - Pipeline by Mechanism of Action 635.5 Acute Pain Therapeutics - Promising Drugs under Clinical Development 645.6 Molecule Profiles for Promising Drugs under Clinical Development 64
5.6.1 MoxDuo IR (morphine and oxycodone) 645.6.2 Dyloject (diclofenac sodium Fast-push Intravenous Bolus Injection) 655.6.3 Ketotransdel (ketoprofen 10% Cream) 665.6.4 MRX-7EAT (etodolac + lidocaine Topical Patch) 675.7 Key Takeaway 676 Acute Pain Therapeutics - Clinical Trials Mapping 686.1 Clinical Trials by Region/Country (The US, EU5 and Japan) 686.2 Clinical Trials by Phase 696.3 Clinical Trials by Trial Status 706.4 Prominent Sponsors 716.5 Top Companies Participating in Acute Pain Therapeutics Clinical Trials 737 Acute Pain Therapeutics - Strategic Assessment 747.1 Key Events Impacting the Future Market 747.2 Acute Pain Therapeutics: Implications for Future Market Competition 748 Acute Pain Therapeutics - Future Players 768.1 Introduction 768.2 Company Profiles 778.2.1 Grunenthal 778.2.2 QRxPharma 778.2.3 Iroko Pharma 788.2.4 Hospira 788.2.5 Transdel Pharma 788.2.6 MEDRx Co. 799 Acute Pain Therapeutics - Appendix 809.1 Definitions 809.2 Acronyms 809.3 Bibliography 819.4 Research Methodology 829.4.1 Coverage 839.4.2 Secondary Research 839.4.3 Forecasting 839.4.4 Primary Research 869.4.5 Expert Panel Validation 879.5 Contact Us 879.6 Disclaimer 87Related Reports @ http://www.reportsnreports.com/publisher/globaldata/Contact:TX, Dallas North - Dominion Plaza,17304, Preston Road,Suite 800, Dallas 75252.
Tel: + 1 888 391 firstname.lastname@example.orgConnect With Us: